VIPPSTAR-G1 Digital Early Intervention for Visual Impairment

计划入组 150 人 · 首次发布于 2026 年 7 月 21 日

Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis

计划入组 16 人 · 首次发布于 2024 年 11 月 14 日

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

计划入组 170 人 · 首次发布于 2023 年 6 月 13 日

SEA-BCMA

Alnuctamab

Cibisatamab

G1 Therapeutics

United States

HUALAN BIOLOGICAL ENGINEERING. INC.

China Resources Boya Bio-pharmaceutical Group Co., Ltd

China

Promising Phase 1/2 Results for ACELYRIN's Lonigutamab Support Buy Rating

Upstream Bio Secures $200 Million in Series B Funding to Advance UPB-101 for Inflammatory Diseases

Health Canada Approves Vabysmo Pre-Filled Syringe for Vision Loss